GS-441524
GS-441524 Uses, Dosage, Side Effects, Food Interaction and all others data.
GS-441524 is an adenosine nucleotide analog antiviral, similar to remdesivir. This molecule was patented in 2009. In vitro studies of GS-441524 have determined it has a higher EC50 than remdesivir against a number of viruses, meaning GS-441524 is less potent. GS-441524 continues to be studied in the treatment of Feline Infectious Peritonitis Virus, a coronavirus that only infects cats.
Trade Name | GS-441524 |
Generic | GS-441524 |
Type | |
Formula | C12H13N5O4 |
Weight | Average: 291.267 Monoisotopic: 291.096753919 |
Groups | Experimental |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
GS-441524 is an experimental nucleoside analog antiviral investigated for its use in the treatment of Ebola and SARS-CoV-2 infections.
How GS-441524 works
GS-441524 is phosphorylated 3 times to form the active nucleoside triphosphate, which is incorporated into the genome of virions, terminating its replication.
Elimination Route
GS-441524 has been found to transport poorly into cells compared to remdesivir.
Innovators Monograph
You find simplified version here GS-441524